Merck’s Q2 Sales Surge 31% to USD 14.6B, Led by Keytruda and China Growth
US-based Merck, Sharp & Dohme (MSD, NYSE: MRK) reported Q2 2022 global sales of USD...
NYSE: MRK
Organon’s China Head Shi Wang Departs to Lead Sanofi Greater China
Women’s health specialist Organon (NYSE: OGN) announced the departure of its former China unit head...